25 May 2013
Keywords: Sanofi, Multaq, USA, FDA, Label warning, Aubagio, Multiple sclerosis, MS
Article | 20 December 2011
The US Food and Drug Administration (FDA) has completed a safety review of French drug major Sanofi’s (Euronext: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 December 2011
24 May 2013
© 2013 thepharmaletter.com